30 closest matches · ranked by relevance
Eustachian Tube Dysfunction · Facial Pain
Primary: Eustachian Tube Dysfunction (ETD) Symptom Visual Analog Scale (VAS) - Total Score — 59.6 score on a scale
Sinusitis · Opioid Use · Opioid Abuse
Primary: Pain Severity — 12.4; 8.5 units on a scale
Nasal Polyps
Primary: TOTAL POLYP SCORE (TPS) — 4.67; 5.24 units on a scale — p=<0.05
Acute Respiratory Infections · Acute Rhinosinusitis
Primary: SNOT-16 Score (Sino-Nasal Outcomes Test) at Day 3 — 1.12; 1.14 Units on a scale — p=0.83
Deviated Nasal Septum
Primary: Post Operative Pain Scores — 3.9; 3.8; 2.7; 2.9 pain score on a scale of 0-10
Facial Pain · Rhinosinusitis
Primary: Change in Mean Number of Days Per Month With Significant Mid-facial Pain or Pressure — -6.0; -5.8 days per month — p=0.96
Sinusitis
Primary: Change in SNOT-20 Score — 2.3; 0.7 score on a scale — p=<0.0001
Sinusitis
Primary: Presence of Mucus in the Paranasal Sinuses (Outcome Measure Percentage of Patients) — 71; 57; 33 percentage of patients — p=<0.05
Post-operative Pain · Sinus Surgery
Primary: Number of Doses of Opiate (Narcotic) Pain Medication — 1.0; 1.5 number of doses
Sinusitis · Cystic Fibrosis
Primary: Computed Tomography Evidence of Less Sinus Disease — 5.875; 3 units on a scale — p=0.2
Pain, Postoperative
Primary: Postoperative Pain Assessed on Standard VAS Scale — 0.48; 1.12 units on a scale
Chronic Sinusitis
Primary: Pain Level Assessed Using a Visual Analogue Scale (VAS) Scale — 0; 0; 0; 2 units on a scale
Acute Rhinosinusitis
Primary: Major Symptom Score (MSS) Assessed by the Investigator — 2.38; 3.41 units on a scale
Rhinosinusitis
Primary: Change of Inflammation of the Nasal Mucosa and Paranasal Sinus — 0; -0.8 score on a scale
Sinusitis
Primary: the Effect of Squeezable Bottle and Syringe on Clinical Effectiveness in Sinusitis Children — 6.56; 6.89; 2.17; 1.24 units on a scale — p=<0.05
Chronic Sinusitis With Nasal Polyps and Eosinophilia
Primary: Ratio to Baseline in Peripheral Blood Eosinophil Counts After 6 Months of Treatment — 0.06 ratio to baseline — p=< 0.001
Pain Management
Primary: Participant Pain Control — 4.5; 5.87; 4.63; 5.00 units on a scale — p=0.16
Chronic Rhinosinusitis (Diagnosis)
Primary: Pain Visual Analogue Scale (VAS) — 3.3; 2.3 units on a scale — p=<0.05
Sinusitis
Primary: Percentage of Subjects With Clinical Cure (Modified Intent-to-Treat (MITT)) — 78.1; 66.7; 19.2; 33.3 Percentage of subjects — p=0.189
Chronic Sinusitis
Primary: Number of Sinuses With Patency of Sinus Ostium After Sinuplasty — 247 Sinuses
Sinusitis
Primary: Subjective Improvement - Day 3 (Rating of "a Lot Better" or "no Symptoms") — 33; 31; 22; 33 Participants
Chronic Sinusitis
Primary: Device Placement Success Rate — 100; 95.2 Percentage of attempted sinuses
Chronic Rhinosinusitis
Primary: Mean Reduction in SNOT-20 Scores — 1.8; 5.5 units on a scale — p=0.23
Sinusitis
Primary: Change in Computed Tomography (CT) Score After Treatment — -.64; -.63; -.5; -.5 units on a scale
Sinusitis
Primary: Technical Success: Sinuses Successfully Treated With Balloon Dilation — 157 sinus dilation attempts
Sinusitis
Primary: Number of Adverse Device Effects — 0 events
Chronic Sinusitis · Nasal Polyposis
Primary: Nasal Obstruction/Congestion Score — 2.36; 2.35; 1.56; 1.79 units on a scale — p=0.0074
Chronic Sinusitis
Primary: SNOT-20 Scores at 12 Weeks — 7; 11 units on a scale
Chronic Rhinosinusitis (CRS) With and Without Nasal Polyps
Primary: Change From Baseline in Facial Pain/Pressure/Fullness on NRS at 2 Hours Post-Dose — -2.70; -2.61 Scores on a scale — p=0.7782
Chronic Rhinosinusitis
Primary: Change in Rhinosinusitis Disability Index (RSDI) Score — -8.000; -14.82 units on a scale — p=0.505